ATH 0.00% 0.3¢ alterity therapeutics limited

AGM, page-14

  1. 516 Posts.
    lightbulb Created with Sketch. 13
    Most people may think if they avoid talking about problems, there is no problem. If you keep telling something not entertaining, you must be a basher. Some problems are always there, trial planning before/after Imagine, investor communication before/after PCH. The biggest problem is this company is getting worse and worse like its share price. Now they have been backed into a corner. It is too late to complain already. Do you still think they have other options? I do hope Prana's "strong" package is good enough for EMA to trash FDA's conclusion. Otherwise GK should resort to some kind of proposal to avoid further depreciation and the waste of resource.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.